B6.129P2-Tln1tm4.1Crit/CritH

Status

Available to order

EMMA IDEM:04999
Citation informationRRID:IMSR_EM:04999 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129P2-Tln1tm4.1Crit/CritH
Alternative nameTln1(tm4.1Crit)
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolTln1tm4.1Crit
Gene/Transgene symbolTln1

Information from provider

ProviderSue Monkley
Provider affiliationBiomedical Services, University of Leicester
Additional ownerProf David Critchley, Dept of Biochemistry, University of Leicester, Leicester, UK
Genetic informationConditional talin 1 allele with loxP sites upstream of the 1st coding exon and downstream of the 4th coding exon. Cre-mediated deletion of exons 1-4 results in a null allele.
Phenotypic informationThe homozygous floxed Tln1 mice are viable and fertile and do not exhibit evidence of any phenotype.
Breeding historyThe line was generated with a floxed neo cassette that was deleted by crossing to cre-deleter mice. The allele was then backcrossed to C57BL/6 and then intercrossed to generate homozygous mice. The allele is maintained as homozygous.
References
  • Talin is required for integrin-mediated platelet function in hemostasis and thrombosis.;Petrich Brian G, Marchese Patrizia, Ruggeri Zaverio M, Spiess Saskia, Weichert Rachel A M, Ye Feng, Tiedt Ralph, Skoda Radek C, Monkley Susan J, Critchley David R, Ginsberg Mark H, ;2007;The Journal of experimental medicine;204;3103-11; 18086863
  • Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo.;Nieswandt Bernhard, Moser Markus, Pleines Irina, Varga-Szabo David, Monkley Sue, Critchley David, Fässler Reinhard, ;2007;The Journal of experimental medicine;204;3113-8; 18086864
  • Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions.;Conti Francesco J, Monkley Sue J, Wood Malcolm R, Critchley David R, Müller Ulrich, ;2009;Development (Cambridge, England);136;3597-606; 19793892
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom
Animals used for archivinghomozygous C57BL/6.129/Sv males
Breeding at archiving centreMales were archived upon arrival. No breeding was performed at the archiving centre.

Disease and phenotype information

MGI phenotypes (gene matching)
  • abnormal embryo development / MGI
  • abnormal ectoderm development / MGI
  • abnormal mesoderm development / MGI
  • decreased embryo size / MGI
  • embryonic growth arrest / MGI
  • abnormal embryonic tissue morphology / MGI
  • abnormal extraembryonic tissue morphology / MGI
  • abnormal gastrulation movements / MGI
  • disorganized extraembryonic tissue / MGI
  • abnormal trophoblast layer morphology / MGI
  • abnormal extraembryonic mesoderm development / MGI
  • embryonic lethality, complete penetrance / MGI
  • embryonic lethality between somite formation and embryo turning, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • abnormal proamniotic cavity morphology / MGI
  • abnormal amniotic cavity morphology / MGI
  • absent ectoplacental cavity / MGI
  • small proamniotic cavity / MGI
  • absent extraembryonic coelom / MGI
  • small amniotic cavity / MGI
  • embryonic-extraembryonic boundary constriction / MGI

Literature references

  • Talin is required for integrin-mediated platelet function in hemostasis and thrombosis.;Petrich Brian G, Marchese Patrizia, Ruggeri Zaverio M, Spiess Saskia, Weichert Rachel A M, Ye Feng, Tiedt Ralph, Skoda Radek C, Monkley Susan J, Critchley David R, Ginsberg Mark H, ;2007;The Journal of experimental medicine;204;3103-11; 18086863
  • Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo.;Nieswandt Bernhard, Moser Markus, Pleines Irina, Varga-Szabo David, Monkley Sue, Critchley David, Fässler Reinhard, ;2007;The Journal of experimental medicine;204;3113-8; 18086864
  • Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions.;Conti Francesco J, Monkley Sue J, Wood Malcolm R, Critchley David R, Müller Ulrich, ;2009;Development (Cambridge, England);136;3597-606; 19793892

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).